Mar 08, 2025
GSK
At GSK we see a world in which advanced applications of machine learning and AI will allow us to develop novel therapies to existing diseases and to quickly respond to emerging or changing diseases with personalized drugs, driving better outcomes at reduced cost with fewer side effects. It is an ambitious vision that will require the development of products and solutions at the cutting edge of machine learning and AI. If that excites you, we'd love to chat. The AI/ML Biomedical AI Team applies machine learning and AI methods to questions at the start and end of the journey of drug development. Our viral evolution group is focused on applying these techniques to support the development of cutting-edge treatments and prevents for viral diseases like Influenza, RSV, and COVID-19. We wish to see humanity fully realize the potential of new platforms like mRNA vaccines, oligonucleotides, and monoclonal antibodies when combating infectious diseases. To do so we model viral...
Professional Diversity Network
South San Francisco, CA, USA
Full-Time